Observational × Hematologic Neoplasms × Plasma cell × Clear all LTFS
Enrolling by invitation
150 enrolled
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Recruiting
10,000 enrolled
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Active not recruiting
153 enrolled
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
Enrolling by invitation
1,000 enrolled
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Recruiting
100 enrolled
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
Active not recruiting
350 enrolled
Cardio CAR-T
Recruiting
60 enrolled
MMYLIFE
Recruiting
190 enrolled
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
Completed
100 enrolled
SANGUINE
Unknown
3,000 enrolled
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
Completed
51 enrolled 8 charts
HMvax-Regist
Withdrawn
HemaTMA
Active not recruiting
5,000 enrolled
ENROL
Recruiting
37,090 enrolled
COVID19-hematological Malignancies: the Italian Hematology Alliance
Unknown
250 enrolled
AutoCOVID-19
Completed
20 enrolled
THERMAL
Unknown
20 enrolled
HemoDiag
Recruiting
500 enrolled
Rehabilitation Needs of the Malaysian Haematological Cancer Survivors
Completed
168 enrolled
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Completed
11 enrolled
GAH
Completed
363 enrolled
N1
Terminated
23 enrolled
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
Completed
99 enrolled
Comprehensive Frailty Assessment
Completed
111 enrolled
A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
Completed
117 enrolled
Fungemia in Hematologic Malignancies
Completed
300 enrolled
ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.
Completed
11 enrolled
VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands
Completed
331 enrolled
Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
Terminated
15 enrolled
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
Completed
44 enrolled
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
Completed
801 enrolled